135 related articles for article (PubMed ID: 6291815)
1. Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension.
Vecsei P; Abdelhamid S; Haack D; Lichtwald K; Lewicka S; von Mittelstädt G
Clin Exp Hypertens A; 1982; 4(9-10):1759-70. PubMed ID: 6291815
[TBL] [Abstract][Full Text] [Related]
2. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
3. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas.
Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Hosojima H; Uchida K; Morimoto S
Horm Res; 1984; 19(4):224-31. PubMed ID: 6745843
[TBL] [Abstract][Full Text] [Related]
4. Adrenal tumor producing 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone and aldosterone.
Toyoda Y; Mizukoshi M; Umemoto M; Kuchii M; Ueyama K; Tomimoto S; Baba A; Shima H; Nishio I; Masuyama Y
Intern Med; 1996 Feb; 35(2):123-8. PubMed ID: 8680100
[TBL] [Abstract][Full Text] [Related]
5. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Kem DC; Tang K; Hanson CS; Brown RD; Painton R; Weinberger MH; Hollifield JW
J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
[TBL] [Abstract][Full Text] [Related]
6. Adrenal adenoma with excess secretion of corticosterone and 18-hydroxycorticosterone.
Morioka M; Sen Y; Inoue K; Fujita Y
J Urol; 1990 Sep; 144(3):731-2. PubMed ID: 2388339
[TBL] [Abstract][Full Text] [Related]
7. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Uchida K; Kigoshi T; Iwasaki R; Morimoto S
Jpn J Med; 1989; 28(4):446-51. PubMed ID: 2554039
[TBL] [Abstract][Full Text] [Related]
8. Comparative biosynthetic studies in a case of primary aldosteronism.
Dahl V; Scattini CM; Lantos CP
J Steroid Biochem; 1976 Sep; 7(9):715-7. PubMed ID: 185466
[No Abstract] [Full Text] [Related]
9. Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma.
Takeda Y; Lewicka S; Koch S; Bige K; Vecsei P; Abdelhamid S; Cojocaru M; Harnik M
J Steroid Biochem Mol Biol; 1990 Nov; 37(4):599-604. PubMed ID: 2278845
[TBL] [Abstract][Full Text] [Related]
10. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
Biglieri EG; Schambelan M
J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
[TBL] [Abstract][Full Text] [Related]
11. Periodic hypokalaemic paralysis, adrenal adenoma, and normal colonic transport of sodium and potassium.
Richards P; Jones MB; Peart WS
Gut; 1973 Jun; 14(6):478-84. PubMed ID: 4719216
[TBL] [Abstract][Full Text] [Related]
12. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension.
Semple PF; Mason PA; Fraser R
Clin Endocrinol (Oxf); 1980 May; 12(5):473-81. PubMed ID: 7428185
[TBL] [Abstract][Full Text] [Related]
13. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.
Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI
Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982
[TBL] [Abstract][Full Text] [Related]
14. Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland.
Saito T; Ikoma A; Saito T; Tamemoto H; Suminaga Y; Yamada S; Kawakami M; Suzuki T; Sasano H; Ishikawa SE
Endocr J; 2007 Apr; 54(2):287-93. PubMed ID: 17379961
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
Sowers JR; Beck FW
Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
[TBL] [Abstract][Full Text] [Related]
16. Zona fasciculata origin of 18-hydroxycorticosterone in the chronically suppressed zona glomerulosa.
Kater CE; Biglieri EG
J Clin Endocrinol Metab; 1982 Oct; 55(4):628-33. PubMed ID: 7107809
[No Abstract] [Full Text] [Related]
17. Suppression of adrenal mineralocorticoid production in prehypertensive young adult men.
Guthrie GP; Kotchen TA; Kotchen JM
J Clin Endocrinol Metab; 1983 Jan; 56(1):87-92. PubMed ID: 6292257
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone metabolites and possible aldosterone precursors in hypertension.
Vecsei P; Abdelhamid S; Mittelstädt GV; Lichtwald K; Haack D; Lewicka S
J Steroid Biochem; 1983 Jul; 19(1A):345-51. PubMed ID: 6887870
[TBL] [Abstract][Full Text] [Related]
19. A rare case of ACTH-independent macronodular adrenal hyperplasia associated with aldosterone-producing adenoma.
Hayakawa E; Yoshimoto T; Hiraishi K; Kato M; Izumiyama H; Sasano H; Hirata Y
Intern Med; 2011; 50(3):227-32. PubMed ID: 21297325
[TBL] [Abstract][Full Text] [Related]
20. The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17 alpha-hydroxylase deficiency syndrome.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
J Clin Endocrinol Metab; 1982 Aug; 55(2):295-302. PubMed ID: 7045152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
